Implantation of l-125 in localized carcinoma of the prostate; technique and results in 100 patients in Utrecht University Hospital;Jodium-125-implantatie bij gelokaliseerd prostaatcarcinoom; techniek en resultaten bij 100 patienten in bet academisch ziekenhuis utrecht

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 20, 1998, Pages 1146-1151

  Battermann, J J ^a   Zeijlemaker, B Y W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; COHORT ANALYSIS; FOLLOW UP; MICTURITION; PROSTATE CANCER; PROSTATECTOMY; SURGICAL TECHNIQUE;

BRACHYTHERAPY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASM METASTASIS; PERINEUM; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REMISSION INDUCTION; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032537315     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer in the United States, 1974-1990. CA Cancer J Clin 1993;43:83-91.
2. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at to years J Urol 1994;152(5 Pt 2):1831-6.
3. Perez CA, Hanks GE, Leibel SA, Zietman AL, Fuks Z, Lee WR. Localized carcinoma of the prostate (stages T1B, T1C, T2 and T3). Review of management with external beam radiation therapy. Cancer 1993;72:3156-73.
4. Porter AT, Blasko JC, Grimm PD, Reddy SM, Ragde H. Brachytherapy for prostate cancer. CA Cancer J Clin 1995;45:165-78.
5. Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, et al. Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. J Urol 1995;154:2144-8.
6. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA 1993;269:2650-8.
7. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
8. Tretli S, Engeland A. Haldorsen T, Hakulinen T, Horte LG, Luostannen T, et al. Prostate cancer - look to Denmark [letter]? J Natl Cancer Inst 1996;88:128.
9. Garnick MB. The dilemmas of prostate cancer. Sci Am 1994;270:72-81
10. Blasko JC, Ragde H, Luse RW, Sylvester JE, Cavanagh W, Grimm PD. Should brachytherapy be considered a therapeutic option in localized prostate cancer? J Urol Clin North Am 1996;23:633-50.
11. Roeleveld TA, Horenblas S, Moonen LMF, Velde A te, Meinhardt W, Bartelink H. Inwendige radiotherapie bij prostaatcarcinoom; tegenvauende langetermijnresultaten van retropubische Jodium-125-implantatie. Ned Tijdschr Geneeskd 1996;140:1855-9.
12. Zelefsky MJ, Whitmore jr WF. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. J Urol 1997;158:23-30.
13. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 1983;130:283-6.
14. Kaye KW, Olson DJ, Payne JT. Detailed preliminary analysis of 125iodine implantation for localized prostate cancer using percutaneous approach. J Urol 1995;153(3 Pt 2):1020-5.
15. Wallner K, Roy J, Zelefsky M, Fuks Z, Harrison L. Short-term freedom from disease progression after I-125 prostate implantation. Int J Radiat Oncol Biol Phys 1994;30:405-9.
16. Vicini FA, Horwitz EM, Gonzalez J, Martinez AA. Treatment options for localized prostate cancer based on pretreatment serum prostale specific antigen levels. J Urol 1997;158:319-25.
17. Beyer DC, Priestley jr JB. Biochemical disease-free survival following 125I prostate implantation. Int J Radiat Oncol Biol Phys 1997;37:559-63.
18. Moerland MA, Wijrdeman HK, Beersma R, Bakker CJG, Battermann JJ. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;37:927-33.
19. Battermann JJ, Boon TA, Voogt HJ de. Preliminary results with iodine-125 seeds for permanent implantation in patients with localized prostatic cancer. Radiother Oncol 1987;10:91-5
20. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatec-tomy for clinically localized (stage T2C or lower) prostate cancer. J Urol 1994;152(5 Pt 2):1850-7.